Evidence map›Paper›PMID 41081986›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026

Multicenter evaluation of the QuickMIC

Anna Olsson, Alexandra Rafeletou, Amanda Åman, Nicolette Athanasiou, Celia García-Rivera, Derek Gerstbrein, Brian Mesich, Logan Patterson, Julia Vahturova, Nicole VanZeeland and 8 more

Abstract readMulticenter StudyComparative StudyEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Anna OlssonGradientech AB, Dag Hammarskjölds väg 36B, Uppsala, 75237, Sweden.
Alexandra RafeletouGradientech AB, Dag Hammarskjölds väg 36B, Uppsala, 75237, Sweden.
Amanda ÅmanGradientech AB, Dag Hammarskjölds väg 36B, Uppsala, 75237, Sweden.ORCID http://orcid.org/0009-0003-0785-9512
Nicolette AthanasiouDepartment of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
Celia García-RiveraAlicante Institute for Health and Biomedical Research (ISABIAL), Dr. Balmis University General Hospital, Alicante, Spain.ORCID http://orcid.org/0000-0003-1701-2916
Derek GerstbreinDepartment of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
Brian MesichDepartment of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0009-0001-1387-1134
Logan PattersonDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.ORCID http://orcid.org/0000-0002-4825-0565
Julia VahturovaClinical Microbiology Laboratory, East-Tallinn Central Hospital, Tallin, Estonia.
Nicole VanZeelandDepartment of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0001-6968-3135
Andrea Ricart-SilvestreAlicante Institute for Health and Biomedical Research (ISABIAL), Dr. Balmis University General Hospital, Alicante, Spain.
Matthew L FaronDepartment of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
Jessica HoffDepartment of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
Kevin AlbyDepartment of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0003-4637-8474
Marina IvanovaClinical Microbiology Laboratory, East-Tallinn Central Hospital, Tallin, Estonia.
Juan Carlos Rodríguez DíazAlicante Institute for Health and Biomedical Research (ISABIAL), Dr. Balmis University General Hospital, Alicante, Spain.
Cecilia JohanssonGradientech AB, Dag Hammarskjölds väg 36B, Uppsala, 75237, Sweden.ORCID http://orcid.org/0000-0001-5965-2853
Christer MalmbergGradientech AB, Dag Hammarskjölds väg 36B, Uppsala, 75237, Sweden. christer.malmberg@gradientech.se.ORCID http://orcid.org/0000-0003-3187-8732

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased antibiotic resistance highlights the need for new, rapid antibiotic susceptibility tests to guide therapy, especially in critical disease such as bloodstream infections and sepsis. This study investigates a new ultra-rapid AST system in multiple clinical laboratories, with respect to accuracy, speed and turnaround time in comparison to commonly used AST systems. The QuickMIC system is compared to the commonly used automated AST systems BD Phoenix™ (BD, USA), MicroScan WalkAway plus (Beckman Coulter, USA) and VITEK

Indexed as

Gram-Negative BacteriaAnti-Bacterial AgentsAutomation, LaboratoryBacteremiaBlood CultureGram-Negative Bacterial InfectionsHumansMicrobial Sensitivity TestsTime FactorsAnti-Bacterial AgentsAntimicrobial resistanceDiagnosticsRapid ASTSepsis

Identifiers

PMID41081986
PMCPMC12872699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.